Content about Europe

September 5, 2013

The global market for mobile health apps and other products is expected to reach a value of nearly $21 billion in five years, according to a new report.

DALLAS — The global market for mobile health apps and other products is expected to reach a value of nearly $21 billion in five years, according to a new report.

Market research firm MarketsandMarkets announced Thursday the release of the report, which analyzed the market for mobile health through 2018 in North America, Europe, Asia and elsewhere, forecasting that it would be worth about $20.7 billion by then. The market is currently valued at about $6.3 billion.

August 28, 2013

The global market for drug packaging is expected to experience tremendous growth over the next few years, according to a new report.

NEW YORK — The global market for drug packaging is expected to experience tremendous growth over the next few years, according to a new report.

August 14, 2013

The global prestige beauty market experienced mixed results in the first half of 2013 but the U.S. prestige beauty market posted an 8% gain during the first six months of the year, according to the NPD Group.

PORT WASHINGTON, N.Y. — The global prestige beauty market experienced mixed results in the first half of 2013 but the U.S. prestige beauty market posted an 8% gain during the first six months of the year, according to the NPD Group.

The U.S. prestige beauty industry generated $5 billion in the first six months of the year, an increase of 8%, the NPD Group stated. In Europe, the United Kingdom gained 6%, generating £803 million in prestige beauty sales, while France, Italy, and Spain continued to face challenges in this industry.

August 8, 2013

Campbell Soup Co. has completed the acquisition of Kelsen Group A/S, a producer of baked snacks, including the Kjeldsens and Royal Dansk brands, sold in 85 countries around the world.

CAMDEN, N.J. — Campbell Soup Co. has completed the acquisition of Kelsen Group A/S, a producer of baked snacks, including the Kjeldsens and Royal Dansk brands, sold in 85 countries around the world.

Based in Denmark, Kelsen is a provider in the assortment segment of the sweet biscuits category in China and Hong Kong, where growth in sweet biscuits is outpacing the growth of the $60 billion global sweet biscuits market.

August 8, 2013

Inspired by the open-air markets of Europe, Giant Eagle opened its first Market District food store in Northeast Ohio — a 94,000-square-foot culinary, dining and shopping destination — on Thursday in the Solon Village Shopping Center that the company will staff with a licensed skin care professional and dietitian who will conduct health-and-wellness activities in the store.

CLEVELAND — Inspired by the open-air markets of Europe, Giant Eagle, Inc., opened its first Market District food store in Northeast Ohio — a 94,000-square-foot culinary, dining and shopping destination — today in the Solon Village Shopping Center that the company will staff with a licensed skin care professional and dietitian who will conduct health-and-wellness activities in the store.

August 1, 2013

Reckitt Benckiser named Alexander Lacik, 48, to the position of president, Reckitt Benckiser North America, effective June 2013. Lacik reports directly to Rob de Groot, EVP Europe and North America, and will be a part of the ENA leadership team.

PARSIPPANY, N.J. — Reckitt Benckiser on Thursday named Alexander Lacik, 48, to the position of president, Reckitt Benckiser North America, effective June 2013. Lacik reports directly to Rob de Groot, EVP Europe and North America, and will be a part of the ENA leadership team.

In his new role, Lacik will be responsible for increasing RB's North American market share, creating new innovations in the health, home and hygiene space, and developing Reckitt's "Powerbrands."

July 22, 2013

An announcement Monday by generic drug maker Sandoz gives a glimpse of what could happen in the United States when biosimilars start to become available.

HOLZKIRCHEN, Germany — An announcement Monday by generic drug maker Sandoz gives a glimpse of what could happen in the United States when biosimilars start to become available.

July 9, 2013

General Mills executives shared the company's new product innovation plans during General Mills' annual investor meeting at the New York Stock Exchange.

NEW YORK — Today, General Mills executives shared the company's new product innovation plans during General Mills' annual investor meeting at the New York Stock Exchange.

"Product innovation is the fuel that creates category growth," said Ken Powell, chairman and CEO of General Mills. "We have a robust new product plan, with more than 200 new items being introduced worldwide in the first half of the year alone."

July 2, 2013

Sandoz has started a late-stage clinical trial of a biosimilar version of a drug used to treat autoimmune disorders, hoping the results will support its efforts to win regulatory approval in the United States and Europe.

HOLZKIRCHEN, Germany — Sandoz has started a late-stage clinical trial of a biosimilar version of a drug used to treat autoimmune disorders, hoping the results will support its efforts to win regulatory approval in the United States and Europe.

Sandoz, the generics arm of Swiss drug maker Novartis, said it had started a phase-3 trial of biosimilar etanercept, a knock-off version of Amgen's Enbrel, used to treat chronic plaque-type psoriasis.

June 6, 2013

MySugr Companion, one of Europe's leading and award-winning diabetes apps for iPhone, is now available for download in the U.S. App Store, the app developer announced.

SAN FRANCISCO — MySugr Companion, one of Europe's leading and award-winning diabetes apps for iPhone, is now available for download in the U.S. App Store, the app developer announced Thursday.

Consumer technology has shown a new trend of monitoring fitness and well-being data in products like the Nike+ and Fitbit. "But Type 1 diabetics are the true champions of the quantified self-movement," commented mySugr advisory board member Tim Ferriss. 

May 30, 2013

Molson Coors Brewing Company is showcasing a global lineup of product innovations designed to expand its portfolio and provide consumers with variety as the summer season kicks off. The company has planned new releases in Canada, Europe and the United States.

DENVER & MONTREAL — Molson Coors Brewing Company is showcasing a global lineup of product innovations designed to expand its portfolio and provide consumers with variety as the summer season kicks off. The company has planned new releases in Canada, Europe and the United States.

May 9, 2013

Costco Wholesale is touting its latest offering to members: its own travel agency.

ISSAQUAH, Wash. — Costco Wholesale Corp. is touting its latest offering to members: its own travel agency.

Costco Connection, the club retailer's monthly member magazine, featured on the cover a profile of Costco Travel, which offers travel packages to destinations ranging from Hawaii and Las Vegas to Europe and Tahiti.

May 2, 2013

Skin care brand Beiersdorf announced on Thursday that it has “continued last year’s positive trend in the first quarter of 2013.”

HAMBURG, Germany — Skin care brand Beiersdorf announced on Thursday that it has “continued last year’s positive trend in the first quarter of 2013.”

Organic group sales rose by 5.4%, and nominal sales increased by 2.9%, from €1,533 million to €1,577 million. The key driver for this positive performance was the double-digit sales growth recorded in emerging markets, the company stated. Consolidated profit after tax rose to €155 million.
 

May 2, 2013

Energizer Holdings had sales of $1.095 billion in second quarter 2013, a 0.5% decrease from second quarter 2012, and $2.28 billion for the first six months of the fiscal year, which ended March 31, also a 0.5% decrease from the same period last year, the company said.

ST. LOUIS — Energizer Holdings had sales of $1.095 billion in second quarter 2013, a 0.5% decrease from second quarter 2012, and $2.28 billion for the first six months of the fiscal year, which ended March 31, also a 0.5% decrease from the same period last year, the company said.

Profits for the quarter were $85 million, compared with $78 million last year.

April 24, 2013

Generic drug maker Hospira marked its fifth year marketing knock-off versions of biotech drugs in Europe Wednesday as it presented at the 2013 Biotechnology Industry Organization International Convention this week.

CHICAGO — Generic drug maker Hospira marked its fifth year marketing knock-off versions of biotech drugs in Europe Wednesday as it presented at the 2013 Biotechnology Industry Organization International Convention this week.

The drug maker said it delivered more than 5 million doses of biosimilar medicines to patients in Europe and Australia. The convention includes multiple sessions devoted to such topics as biosimilar regulatory approval, manufacturing and market formation, the company said.

April 22, 2013

Difrax is selling its brand of three-stage pacifiers in the United States, the company said.

NEW YORK — Difrax is selling its brand of three-stage pacifiers in the United States, the company said.

April 21, 2013

It's official. During its most recent quarterly conference call with analysts, CVS Caremark revealed what many had anticipated: Its acquisition of privately held Brazilian drug store chain Drogaria Onofre was complete.

It's official. During its most recent quarterly conference call with analysts, CVS Caremark revealed what many had anticipated: Its acquisition of privately held Brazilian drug store chain Drogaria Onofre was complete.

The move is not financially material to CVS Caremark, but it does mark its first foray into the international drug store space. The 44-store chain is the eighth-largest drug store chain in Brazil and, according to published reports, posted gross revenue of R$1.2 billion (Brazilian reals) in 2011.

April 8, 2013

Weis Markets on Sunday celebrated the completion of its Hamburg location remodel and upgrade.

SUNBURY, Pa. — Weis Markets on Sunday celebrated the completion of its Hamburg location remodel and upgrade.

The store’s pharmacy, which was once a separate location, has been integrated into the store. In addition, the store’s HBC section has been relocated and is now adjacent to the pharmacy.

The store now features all new décor, a new exterior and expanded food service options, including in-store pizza and an upgraded bakery. 

April 5, 2013

Novo Nordisk has launched a diabetes awareness sweepstakes in which the winners get a free trip to the 2013 IndyCar finale, the Danish drug maker said.

BIRMINGHAM, Ala. — Novo Nordisk has launched a diabetes awareness sweepstakes in which the winners get a free trip to the 2013 IndyCar finale, the Danish drug maker said Friday.

The company announced that it had hired IZOD IndyCar Series Charlie Kimball as spokesman for its Race with Insulin contest. Kimball, the first licensed driver with diabetes to race at the highest level of the series, was diagnosed with the disease during a routine doctor visit in 2007 while racing in Europe and is a user of Novo Nordisk's NovoLog (insulin aspart [rDNA origin]).

February 28, 2013

Biosimilar medicines have been approved and routinely prescribed in Europe for nearly seven years, and creation of a clear pathway for Food and Drug Administration review and approval of generic versions of bioengineered drugs was enshrined into law in the United States with the passage of the Patient Protection and Affordable Care Act nearly three years ago.

Biosimilar medicines have been approved and routinely prescribed in Europe for nearly seven years, and creation of a clear pathway for Food and Drug Administration review and approval of generic versions of bioengineered drugs was enshrined into law in the United States with the passage of the Patient Protection and Affordable Care Act nearly three years ago. But IMS Health and other industry experts agree it could still be years before biosimilars are available to pharmacies and patients in this country.

February 13, 2013

Slated to hit the U.S. retail market in April is the new Neovadiol range from Vichy Laboratoires, a leading pharmacy skin care line for the signs of hormonal aging.

NEW YORK — Slated to hit the U.S. retail market in April is the new Neovadiol range from Vichy Laboratoires, a leading pharmacy skin care line for the signs of hormonal aging in Europe and Canada.

The new Neovadiol Gf Lip & Eye Contours and Neovadiol Lumiere BB Cream complete the range, which already includes day and night creams. The Neovadiol range was developed in consultation with experts like dermatologists, obstetricians, gynecologists and psychologists.

February 13, 2013

Walgreens and Alliance Boots will generate $130 billion or more in combined sales, Greg Wasson, Walgreens president and CEO told analysts Wednesday.

LONDON — Walgreens and Alliance Boots will generate $130 billion or more in combined sales, Greg Wasson, Walgreens president and CEO, told analysts Wednesday. Walgreens and Alliance Boots offered analysts a firsthand look at the Alliance Boots operation here, beginning with a store tour and then leading into presentations. 

January 30, 2013

A ban on importing and selling animal-tested cosmetics products and ingredients will enter into force in March. The ban affects all cosmetics, including toiletries and beauty products.

LONDON — A ban on importing and selling animal-tested cosmetics products and ingredients will enter into force in March. The ban affects all cosmetics, including toiletries and beauty products.

"I believe that the ban should enter into force in March 2013 as Parliament and Council already have decided. I therefore am not planning to propose a postponement or derogation to the ban," Commissioner Tonio Borg wrote in a recent letter to animal testing campaigners.

January 7, 2013

While pressure to grow will drive more large drug makers to pursue mergers and acquisitions, diminished resources and competition from biotech and specialty pharmaceutical companies will challenge their ability to do so, according to a new report.

SAN FRANCISCO — While pressure to grow will drive more large drug makers to pursue mergers and acquisitions, diminished resources and competition from biotech and specialty pharmaceutical companies will challenge their ability to do so, according to a new report.

December 10, 2012

Astellas Pharma US has announced the Food and Drug Administration's approval to review the new drug application for tacrolimus extended-release capsules.

NORTHBROOK, Ill. — Astellas Pharma US announced the Food and Drug Administration's review of their new drug application for tacrolimus extended-release capsules, a once-daily formulation of the calcineurin-inhibitor immunosuppressant tacrolimus, for the prophylaxis of organ rejection in adult kidney transplant recipients and adult male liver transplant recipients.